Monopar Therapeutics
MNPR
#6931
Rank
ยฃ0.55 B
Marketcap
ยฃ82.67
Share price
-1.80%
Change (1 day)
226.91%
Change (1 year)

Monopar Therapeutics (MNPR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ1.91 Million

According to Monopar Therapeutics's latest financial reports the company's total liabilities are ยฃ1.91 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Monopar Therapeutics - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ2.14 M-48.74%
2024-12-31ยฃ4.18 M203.53%
2023-12-31ยฃ1.37 M-46.81%
2022-12-31ยฃ2.59 M121.47%
2021-12-31ยฃ1.17 M35.64%
2020-12-31ยฃ0.86 M56.32%
2019-12-31ยฃ0.55 M75.45%
2018-12-31ยฃ0.31 M36.41%
2017-12-31ยฃ0.23 M341.37%
2016-12-31ยฃ0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ15.66 M 718.94%๐Ÿ‡บ๐Ÿ‡ธ USA